Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 262

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 262
---
 allocated to each participant’s individual account
and are then invested in selected investment alternatives according to the participants’ directions. Participants are immediately
and fully vested in their contributions. We match each participant’s contribution up to a safe harbor maximum of 4% of his or her
eligible compensation with participants vesting immediately and fully in such matching contributions. Our 401(k) plan is intended to
be qualified under Section 401(a) of the Code with the 401(k) plan’s related trust intended to be tax exempt under Section 501(a)
of the Code.

<div align='center'>153</div>

Health and Welfare Benefits

We provide benefits to our
named executive officer on the same basis as provided to all of its employees, including health, dental and vision insurance, as well
as life and disability insurance. Legacy CERo did not, and we will not, maintain any executive-specific benefit or perquisite programs.
Benefits were and are anticipated to be offered on the same basis as provided to all of our employees.

Outstanding Equity Awards as of December 31, 2024

The following table sets
forth information regarding outstanding equity awards held by our named executive officers as of December 31, 2024:

| Name                                      |     | Grant Date |     | Vesting      
 Commencement 
 Date         |     | Option Awards 
 Number of     
 Securities    
 Underlying    
 Unexercised   
 Options (#)   
 Exercisable   |        |     | Number of     
 Securities    
 Underlying    
 Unexercised   
 Options (#)   
 Unexercisable |       |     | Option   
 Exercise 
 Price    
 ($)      |       |     | Option     
 Expiration 
 Date       |
|:------------------------------------------|:----|:-----------|:----|:-------------|:----|:--------------|-------:|:----|:--------------|------:|:----|:---------|------:|:----|:-----------|
| Chris                                     
 Ehrlich, Chief Executive Officer          |     | 10/01/2024 |     | 12/02/2024   |     |               | 25,550 |     |               |     - |     | $        | 10.00 |     | 09/30/2034 |
| Brian                                     
 G. Atwood, Former Chief Executive Officer |     | 10/01/2024 |     | 12/02/2024   |     |               |  5,